![Gilles Bernard Tremblay](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gilles Bernard Tremblay
Directeur Technique/Scientifique/R&D chez
Alethia Biotherapeutics, Inc.
Profil
Gilles Bernard Tremblay is currently the Vice President-Research at Alethia Biotherapeutics, Inc. He started this position in 2012.
Previously, he worked as a Group Leader at SignalGene, Inc. Dr. Tremblay holds a doctorate degree from McGill University.
Postes actifs de Gilles Bernard Tremblay
| Sociétés | Poste | Début |
|---|---|---|
Alethia Biotherapeutics, Inc.
 Alethia Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutic mAbs against highly-disease tissue specific novel clinically-relevant targets | Directeur Technique/Scientifique/R&D | 01/01/2000 |
Anciens postes connus de Gilles Bernard Tremblay
| Sociétés | Poste | Fin |
|---|---|---|
SignalGene, Inc. | Corporate Officer/Principal | - |
Formation de Gilles Bernard Tremblay
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
9
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alethia Biotherapeutics, Inc.
Alethia Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutic mAbs against highly-disease tissue specific novel clinically-relevant targets | Health Technology |
SignalGene, Inc. |
